We investigated the interactions of rotaviruses with glycoproteins and cells that support rotaviral replication. We found that a wide range of naturally occurring glycoproteins, including ovalbumins and ovomucoids from chicken and turkey eggs, and mucin derived from bovine submaxillary glands, inhibit the replication of rotaviruses in MA-104 cells. 
Introduction
Rotaviruses are RNA viruses of the family Reoviradae, which have been identified as major etiological agents of symptomatic gastroenteritis in humans and animals (1) (2) (3) (4) . While rotaviruses are known to replicate in a number of tissue culture cell lines and in the intestinal epithelial cells of a wide range of animal species (5-7), little is known about the nature of the interactions of rotaviruses with cells that support rotaviral replication. Re- cently, a number of sialic acid-containing glycoproteins have been identified that modulate the interactions of pathogenic RNA viruses, such as myxoviruses, paramyxoviruses, picornaviruses and reoviruses, with epithelial cells (8) (9) (10) (11) (12) (13) . Because sialic acid-containing glycoproteins are major constituents of the human gastrointestinal tract and also are present in a number of human food products (14-17), such glycoproteins may be important determinants of host susceptibility to enteric infections. We thus investigated the role of sialic acid oligosaccharides on the interactions of viruses and cells and on the ability of rotaviruses to cause gastrointestinal infections in experimental animals.
Methods

Reagents
Viruses. The SA-11 strain of rotavirus (antigenically related to human serotype 3) was originally obtained from Dr. H. Malherbe of Salt Lake City, UT and propagated in MA-104 cells using previously described methods (18) . The WA (human serotype 1) and NCDV (bovine, serotype 6) strains of rotavirus were obtained from Dr. Richard Wyatt, National Institutes of Health, Bethesda, MD. The VA-70 (human, serotype 4) strain of rotavirus was obtained from Dr. G. Gerna, Milan, Italy. These viruses were propagated in MA-104 cell monolayers using standard cultivation methods, and the viral titers were determined by plaque enumeration ( 19) . Cell lysates from uninfected MA-104 cells were prepared as described by Krah and Crowell (20) . The EDIM strain of murine rotavirus was originally obtained from Dr. Michael Collins, Microbiological Associates, Rockville, MD. Murine rotavirus for animal inoculation was prepared from intestines collected from EDIM virus-infected suckling mice and was purified on CsCl gradients following previously described procedures (21) . The infectivity ofthe purified virus preparation was determined by orally inoculating litters of 5-7-d-old mice with serial 10-fold dilutions of the viral stock. 3 d after inoculation, the mice were evaluated for diarrhea by examining the distal colon for the presence of liquid intestinal contents. The 100% infectious dose was defined as the highest dilutions of virus that produced diarrhea in all of the inoculated animals. In these studies, all mice inoculated with EDIM virus received a single 100% infectious dose.
Reagents. The following glycoprotein compounds were obtained from Sigma Chemical Company, St. Louis, MO: bovine submaxillary mucin, bovine serum albumin (BSA), chicken ovoinhibitor (type IV-O), chicken ovalbumin, turkey ovalbumin, turkey ovoinhibitor (type II-T), and fetuin. A dried egg white food preparation (spray dried angel-type egg whites) was obtained from Sonstegad Foods, Inc., Howard Lake, MN. These compounds were all found to be free ofimmunoglobulins as determined by enzyme immunoassay analyses (22) . The mucins and ovalbumins were found to be free of protease inhibitory activity as determined by the method of Tidwell et al. (23) . BSA, neuraminidase (from C. perfringens), beta-galactosidase (from E. coli), porcine trypsin, N-acetylneuramin-lactose, sodium borohydride, N-acetyl neuraminic acid, monosaccharides and lectins from Limulus polyphemus and other sources were also purchased from Sigma Chemical Co. Sheep erythrocytes were provided by Dr Assaysystems. The ability ofthe glycoproteins, erythrocytes, or lectins to inhibit rotavirus replication was measured by viral plaque neutralization analyses. Those were modified from assays that were originally developed for the measurement of antirotavirus-neutralizing antibodies (25) . Briefly, MA-104 cells were grown to confluence on 6-or 12-well tissue culture microplates (Nunc A. S., Kamstrup, OK) in the presence ofmodified Eagle's minimum essential medium (EMEM)' and 10% fetal bovine serum at 370C in a CO2 environment. The cells were washed with serum-free media before use. Aliquots ofglycoprotein orerythrocytes were diluted in EMEM with 0.5-1 p-g/ml porcine trypsin, mixed with -100 plaque forming units of virus, and absorbed onto the cells. After incubation at 370C for 1 h the inoculum was decanted, the wells were washed with EMEM, and the cells were overlaid with an agarose mixture composed of 2X EMEM containing 2 sg/ml trypsin and 100 sg/ml DEAE-dextran mixed with an equal volume of 1.4% agarose type I (Sigma Chemical Co). After 48 h another agarose overlay, containing the above material plus neutral red solution at a concentration of 0.1 mg/ml (Gibco, Grand Island, NY), was added to the cells. Plaques, as manifested by areas in which virus-infected cells were not stained with neutral red, were counted by visual inspection. For each concentration of glycoprotein or erythrocytes, a percentage inhibition was calculated by comparing the number of plaques formed in the presence of the glycoprotein with the number of plaques generated in control wells, incubated under similar conditions with virus but without glycoprotein.
In certain cases, the oligosaccharides ofthe glycoproteins were chemically reduced before testing by reaction with sodium borohydride with a method modified from that of Gentsch and Pacitti (12). For these reactions, a 10-mg aliquot of the glycoprotein was suspended in 1 ml of 0.1 M NaOH-0.8 M NaBH4 and incubated for 14 h at 370C with constant magnetic stirring. At the end of the incubation, an additional 0.5-ml aliquot of NaOH-NaBH4 was added and the sample was incubated for an additional 4 h at 370C. The sample was then immediately cooled to 4VC, and the concentration of NaBH4 was reduced to 0.2 M by the addition of cold H20. The mixture was then adjusted to pH 5 by adding glacial acetic acid. The sample was then dialyzed extensively against 0.01 M phosphate-buffered saline (PBS) and tested as described above. Mock reactions in which PBS was substituted for the NaOH-NaBH4 were performed to control for nonspecific degradation of the glycoprotein and loss during dialysis.
The effect of neuraminidase on the ability of sheep erythrocytes to inhibit replication of rotavirus in vitro was determined by incubating washed erythrocytes at concentrations of 0.1-10% with 5 X l0-3 U of neuraminidase from C. perfringens. After incubation for 2 h at 37°C, the enzyme was removed from the erythrocytes by centrifugation and the cells were washed in EMEM. The enzyme-treated erythrocytes were then added to the MA-104 cells, which were then infected with virus for I h at 37°C. The virus-erythrocyte mixture was decanted, agarose overlay was added, and the cells were processed as described above. Untreated erythrocytes and erythrocytes treated with equivalent concentrations of beta-galactosidase were evaluated in a similar manner to serve as controls.
The effect ofenzymes on the ability ofMA-104 cells to support viral replication was determined by reacting the cells with varying concentrations of neuraminidase from C. perfringens or beta-galactosidase from E. coli for 4 h at 37°C. After this incubation, the enzyme was removed by washing and replaced with EMEM. Virus was then added at measured time intervals following enzymatic treatment, and the cells were monitored for viral replication as described above.
The interaction of bovine submaxillary mucin with rotavirus was investigated by measuring the binding of radiolabeled virus with immobilized mucin. For Microtiter well strips (Immulon II; Dynatech Laboratories, Inc., Alexandria, VA) were coated with bovine submaxillary mucin diluted to 10 Ag/ml in 0.01 M carbonate buffer (pH 9.0). After an overnight incubation at 4VC, the strips were washed five times with PBS containing 0.5% Tween-20 (PBST), and '25I-labeled virus was added to the well.
Following an incubation for 2 h at 370C, the wells were washed five times with PBST, and the amount of 125I binding to the wells was measured by means of standard gamma counting instrumentation (G. D. Searle and Co., Skokie, IL). The binding of virus to the solid phase was documented by eluting the material from the solid phase by reaction with Laemmli buffer (27) . The eluted material was separated by electrophoresis through a 10% polyacrylamide gel for 17 h at 70 V, and the labeled components were identified by autoradiography for -2 d at -70'C with a Quanta III intensifying screen (Dupont Inc., Wilmington, DE).
The ability of oligosaccharides, glycoproteins, and other macromolecules to inhibit the binding of radiolabeled rotavirus to mucin immobilized onto the solid phase was determined by the following method. The potential inhibitor was diluted in PBS, mixed with -100,000 cpm of rotavirus labeled with '25I as described above. The virus-inhibitor mixture was added to microtiter wells coated with mucin as described above. After incubation for 90 min at 370C, the wells were washed with PBST, and the amount of 1251 binding to the wells was counted as described above. For each compound a percentage inhibition was calculated by determining the counts bound to the solid phase mucin in the presence of the added inhibitor, as compared with the binding of equal amounts of virus incubated in PBS under similar reaction conditions.
The ability of the glycoproteins to inhibit the intestinal replication of rotaviruses was evaluated in a murine model of rotavirus infection by the following method. One part of a suspension of EDIM virus containing 10 100%-infectious doses/0.1 ml, prepared as described above, was added to nine parts of the test compound at a concentration of 10 mg/ml and incubated at 370C for 30 min. The stock EDIM virus solution was diluted in PBS containing 0.01 M CaC12 and 0.01 M MgCI2. Test compounds were dissolved in sterile, deionized water. 6-to 8-d-old suckling mice were given 0.1 ml ofthe virus-compound mixture intragastrically via a 24-gauge gastric gavage needle. 2 were directed at determining the effect of a number of naturally occurring glycoproteins on the in vitro replication of rotaviruses as evidenced by the ability of the compounds to inhibit the generation of plaques after the infection of MA-104 cells with the SA-I 1 strain of rotavirus. As depicted in Fig. 1 , incubation of virus with ovomucoid and ovalbumin glycoproteins from turkeys and chickens resulted in 50% inhibition of rotavirus replication at concentrations of <10 jsg/ml. Similarly, a crude preparation of powdered egg white used as a food supplement was also capable of inhibiting 50% of the rotavirus replication at a concentration of <10 ,ug/ml. Incubation of virus with bovine fetuin resulted in a 50% decrease in viral replication at a concentration of <100 ,gg/ml and incubation with bovine submaxillary mucin resulted in 50% inhibition at a concentration between 100 and 1,000 ,ug/ml. The inhibitory effect ofthe glycoproteins was totally eliminated by reduction with 0.8 M sodium borohydride ( Fig.  1) but not by treatment of the glycoproteins with 0.1 M NaOH, extensive dialysis, or heating at 70'C for 30 min. The glycoprotein compounds were also found to inhibit in vitro replication of other strains of rotavirus, including WA (human, serotype 1), and VA-70 (human, serotype 4), strains of virus at concentrations similar to those that inhibited replication of the SA-l 1 strain of rotavirus (data not depicted).
We also investigated the ability of low molecular weight oligosaccharides and other compounds to inhibit replication of SA-l 1. A small amount of inhibition was also noted after in- cells. After addition of an agarose overlay and incubation for 3 d, the number of plaques resulting from the infection of the cells was enumerated as described in the text. For each concentration of glycoprotein the percentage inhibition of rotavirus infection was calculated by comparing the number of plaques generated after incubation of virus with the inhibitor with the number of plaques generated by virus alone. The glycoproteins, oligosaccharides, and egg white preparation were obtained and prepared as described in the text. BSA, bovine serum albumin; NANA, N-acetyl neuraminlactose; Mucin + NaBH4, bovine submaxillary mucin reduced by reaction with sodium borohydride as described in the text. Reaction of the virus with other sugars such as glucose, fructose, galactose, mannose, N-acetyl glucosamine, and N-acetyl galactosamine did not result in any measurable inihibition of rotavirus replication at concentrations up to 1,000 ,g/ml. itory effect of the glycoproteins on the in vitro replication of rotavirus. We thus pretreated MA-104 cells with bovine submaxillary mucin at concentrations of 10 mg/ml for 2 h at 370C but removed the glycoprotein by washing the cells with EMEM before cellular infection. As depicted in Fig. 4 , the removal of the glycoprotein resulted in the elimination ofits inhibitory effect on subsequent rotavirus replication. On the other hand, the incubation of virus with submaxillary mucin at a concentration of 10 mg/ml led to inhibition of viral growth even when the mucin was diluted to a final concentration of as little as 1 cells with virus (Fig. 1) . Similar results were found with the ovalbumin and ovomucoid inhibitors of rotavirus replication.
Interactions with radiolabeled virus. We also investigated the interaction of virus with glycoprotein by measuring the binding of radiolabeled virus to mucin that had been immobilized onto the wells of polystyrene microtiter plates. As depicted in Fig. 5 , bovine submaxillary mucin immobilized onto the solid phase was capable of interacting with rotavirus, as evidenced by the binding of radiolabeled bands that migrated at molecular weight compatible with VP3 and VP7, the major outer capsid proteins of rotaviruses (30, 31) . In addition, radiolabeled virus bound to chicken yolk immunoglobulins containing antirotavirus antibodies and monoclonal antibodies to VP7, as well as sheep erythrocytes and purified preparations of cellular membranes derived from MA-104 cells. On the other hand, radiolabeled virus did not bind to uncoated wells or to wells coated with control yolk immunoglobulins obtained from unimmunized chickens.
We also used this solid phase binding system to investigate the sugar specificity of the binding of virus to mucin. As depicted in Fig. 6 , the binding ofvirus to solid-phase mucin was inhibited by N-acetyl neuraminic acid (sialic acid) at concentrations as low as 3 mM and by N-acetyleneuramin lactose at a concentration of 10 mM. Binding was also inhibited by incubation of the '251I-labeled rotavirus with unlabeled rotavirus and by incubation with cell membrane preparations isolated from MA-104 cells. On the other hand, binding was not inhibited by glucose, fucose, mannose, galactose, N-acetyl glucosamine, or other sugars at concentrations of 100 mM. Binding of virus was also significantly decreased by treatment of the solid-phase mucin with neuraminidase and by chemical reduction ofthe mucin with sodium borohydride.
Effect ofglycoproteins on in vivo replication. We also evaluated the ability of the glycoprotein compounds to inhibit intestinal viral replication in a mouse model of rotavirus infection.
As depicted in Fig. 7 role of sialic acid receptors in the cell-virus interactions ofother RNA viruses, such as reoviruses, enteroviruses, influenza viruses, parainfluenza viruses, and respiratory syncytial viruses (8-13). The possible relationship between sialic acid-containing glycoproteins and cellular binding sites for rotaviruses should be investigated by more detailed analyses of the binding and uptake of rotaviruses by susceptible cells and by the purification and characterization of rotavirus cellular receptors.
In addition to preventing the in vitro replication of rotaviruses, bovine submaxillary mucin and chicken ovoinhibitor were capable ofinhibiting the intestinal replication ofrotaviruses and preventing the development ofsymptomatic rotavirus gastroenteritis in experimentally infected infant mice. Intestinal infection was also reduced by the feeding ofsheep erythrocytes along with virus, whereas erythrocytes treated with neuraminidase were ineffective at reducing infection. These findings suggest that interactions involving sialic acid oligosaccharides are also important in rotavirus infections in vivo. It is of note that, while bovine submaxillary mucin was less effective than the other glycoproteins on a weight basis for the inhibition of rotavirus replication in tissue culture, it proved to be one of the most effective compounds for prevention of rotavirus gastroenteritis in the animal model system. The reasons for the differential efficacy of mucin in the animal model and in vitro systems is not known with certainty but may be related to the nature of rotavirus binding to intestinal cells or to differences in the intestinal metabolism of the glycoproteins. The interaction of mucins with rotaviruses and other pathogenic intestinal viruses is of interest because mucins are secreted by goblet cells located throughout the intestinal tract and mucin secretion can be altered by developmental changes, pathological gastrointestinal disease states, and changes in gastrointestinal microflora (14-17, 28, 29) . It is thus possible that variations in the quantity or character ofmucinous glycoproteins might modulate the intestinal replication of enteric viruses and that differential levels or chemical forms of intestinal glycoproteins might be partially responsible for the well-described age and species determinants of susceptibility to enteric viral infections (1, 2, 34) . In addition, the fact that many food products contain mucinous and other sialic acid-containing glycoproteins (35, 36) suggests that dietary alterations might also have a modulating effect on rotavirus infections.
Our studies suggest that the inhibition ofintestinal replication of rotavirus by means of glycoprotein interactions may be a potential strategy for the modulation of rotavirus infection in humans and animals. The ability to prevent intestinal infection by nonimmunological means might prove to be particularly important for prevention of disease in newborns, immunocompromised patients, and other individuals incapable of mounting an effective immune response to active immunization (37) (38) (39) . In addition, the fact that mucins and other sialic acid-containing glycoproteins can also modulate the in vitro replication of reoviruses ( 12) and the intestinal binding of cholera toxin (40) 
